KR20180052126A - 활성 성분의 제어된, 지연된 방출을 갖는 제제 - Google Patents

활성 성분의 제어된, 지연된 방출을 갖는 제제 Download PDF

Info

Publication number
KR20180052126A
KR20180052126A KR1020187010365A KR20187010365A KR20180052126A KR 20180052126 A KR20180052126 A KR 20180052126A KR 1020187010365 A KR1020187010365 A KR 1020187010365A KR 20187010365 A KR20187010365 A KR 20187010365A KR 20180052126 A KR20180052126 A KR 20180052126A
Authority
KR
South Korea
Prior art keywords
active ingredient
release
tablet
range
rti
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020187010365A
Other languages
English (en)
Korean (ko)
Inventor
핀 바우어
토르슈텐 베델
귄터 모델모크
구드룬 비르크
로베르토 오그니베네
디터 루브다
Original Assignee
메르크 파텐트 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 메르크 파텐트 게엠베하 filed Critical 메르크 파텐트 게엠베하
Publication of KR20180052126A publication Critical patent/KR20180052126A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020187010365A 2015-09-14 2016-08-25 활성 성분의 제어된, 지연된 방출을 갖는 제제 Withdrawn KR20180052126A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP15185028.6 2015-09-14
EP15185028 2015-09-14
EP15189045.6 2015-10-09
EP15189045 2015-10-09
PCT/EP2016/001430 WO2017045742A1 (de) 2015-09-14 2016-08-25 Formulierung mit kontrollierter, verzögerter wirkstoffreisetzung

Publications (1)

Publication Number Publication Date
KR20180052126A true KR20180052126A (ko) 2018-05-17

Family

ID=56855404

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020187010365A Withdrawn KR20180052126A (ko) 2015-09-14 2016-08-25 활성 성분의 제어된, 지연된 방출을 갖는 제제

Country Status (8)

Country Link
US (2) US10874615B2 (enExample)
EP (1) EP3349733A1 (enExample)
JP (1) JP6841819B2 (enExample)
KR (1) KR20180052126A (enExample)
CN (1) CN108024966A (enExample)
AU (1) AU2016321659A1 (enExample)
CA (1) CA2998422A1 (enExample)
WO (1) WO2017045742A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160235709A1 (en) 2012-08-31 2016-08-18 Molecular product management LLC Limited release lingual thioctic acid delivery systems
EP3519812B1 (en) 2016-09-27 2026-05-06 Zolentroff, William C. Ala and salt formulation
JP7238509B2 (ja) * 2019-03-19 2023-03-14 三菱ケミカル株式会社 医薬錠剤

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0096074A4 (en) * 1981-12-18 1984-05-29 Key Pharma EXPANDABLE MESH OF POLYVINYL ALCOHOL AND POLYETHYLENE GLYCOL.
WO1988007366A1 (en) * 1987-03-25 1988-10-06 E.I. Du Pont De Nemours And Company Use of vinyl alcohol homopolymers and copolymers for tableting active materials
US6495656B1 (en) * 1990-11-30 2002-12-17 Eastman Chemical Company Copolyesters and fibrous materials formed therefrom
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
US5838571A (en) * 1996-01-29 1998-11-17 Alza Corporation Tablet press monitoring and controlling method and apparatus
HUP0301415A2 (hu) * 2000-07-06 2003-09-29 Delsys Pharmaceutical Corporation Eljárás megnövelt stabilitású egészségvédż termékek formulázására
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
US7022342B2 (en) * 2002-03-28 2006-04-04 Andrx Corporation, Inc. Controlled release oral dosage form of beta-adrenergic blocking agents
US20060099256A1 (en) * 2002-11-27 2006-05-11 Price James C Microspheres and related processes and pharmaceutical compositions
US7241838B2 (en) * 2003-12-19 2007-07-10 Eastman Chemical Company Blends of aliphatic-aromatic copolyesters with ethylene-vinyl acetate copolymers
US7368503B2 (en) * 2003-12-22 2008-05-06 Eastman Chemical Company Compatibilized blends of biodegradable polymers with improved rheology
US20080152595A1 (en) * 2004-11-24 2008-06-26 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of orally administered pharmaceutical products
US20090098202A1 (en) * 2006-02-10 2009-04-16 Boehringer Ingelheim International Gmbh Extended Release Formulation
US9238073B2 (en) * 2006-04-12 2016-01-19 Wyeth Llc Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive
WO2009048557A1 (en) * 2007-10-10 2009-04-16 Mallinckrodt Baker, Inc. Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof
EP2177213B1 (en) * 2008-09-17 2013-01-02 Siegfried Ltd. Nicotine-containing granulate
AU2010314994B2 (en) * 2009-11-09 2016-10-06 Spotlight Technology Partners Llc Fragmented hydrogels
JP2013241341A (ja) * 2012-05-17 2013-12-05 Nisshin Kasei Kk マトリックス製剤用基剤、及び該基剤を用いた徐放性製剤
GB201412413D0 (en) * 2014-07-11 2014-08-27 Revolymer Uk Ltd Encapsulated benefit agent particles
KR20170038039A (ko) * 2014-07-30 2017-04-05 메르크 파텐트 게엠베하 분상, 직접 압축성 유형의 폴리비닐 알코올

Also Published As

Publication number Publication date
CN108024966A (zh) 2018-05-11
US10874615B2 (en) 2020-12-29
CA2998422A1 (en) 2017-03-23
US20200246270A1 (en) 2020-08-06
US20190038562A1 (en) 2019-02-07
AU2016321659A1 (en) 2018-05-10
WO2017045742A1 (de) 2017-03-23
EP3349733A1 (de) 2018-07-25
JP2018530538A (ja) 2018-10-18
JP6841819B2 (ja) 2021-03-10

Similar Documents

Publication Publication Date Title
JP6629835B2 (ja) 直接圧縮可能なポリビニルアルコール
JP6706245B2 (ja) 微結晶性セルロースを含む直接圧縮可能な組成物
JP2022000430A (ja) 生物学的に活性な物質及び不規則性無機酸化物を含有する組成物
US11040012B2 (en) Pulverulent, directly compressible polyvinyl alcohol grades
US20200246270A1 (en) Formulation having controlled, delayed release of active ingredient
AU2012288632B2 (en) New (trimethoxyphenylamino)pyrimidinyl formulations
EP2077822B1 (en) Oxcarbazepine-containing oral formulation and a process to obtain the same
KR20190095373A (ko) 연장된 활성 물질 전달을 갖는 정제를 제조하기 위한 직접 타정성 매트릭스
US20180250233A1 (en) Tablets having media independent active substance delivery
EP4410278A1 (en) Pharmaceutical composition comprising enavogliflozin
EP2968167A1 (en) Dosage form comprising crizotinib
HK40026299A (en) Bromocriptine formulations
HK40026299B (en) Bromocriptine formulations

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20180412

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid